K M Plain - JoVE Visualize

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998

Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4B M Hall, L Fava, J Chen, et al.

Transplantation|February 12, 1998

Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokinesK M Plain, L Fava, A Spinelli, et al.

Heliyon|June 29, 2019

The immunogenicity and tissue reactivity of Mycobacterium avium subsp paratuberculosis inactivated whole cell vaccine is dependent on the adjuvant usedD J Begg, O Dhungyel, A Naddi, et al.

International Immunology|August 30, 2001

Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4G T Tran, N Carter, X Y He, et al.

Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Journal of Immunology (Baltimore, Md. : 1950)|November 20, 1998

Anti-CD4 monoclonal antibody-induced tolerance to MHC-incompatible cardiac allografts maintained by CD4+ suppressor T cells that are not dependent upon IL-4B M Hall, L Fava, J Chen, et al.

Transplantation|February 12, 1998

Induction of tolerance with nondepleting anti-CD4 monoclonal antibodies is associated with down-regulation of TH2 cytokinesK M Plain, L Fava, A Spinelli, et al.

Heliyon|June 29, 2019

The immunogenicity and tissue reactivity of Mycobacterium avium subsp paratuberculosis inactivated whole cell vaccine is dependent on the adjuvant usedD J Begg, O Dhungyel, A Naddi, et al.

International Immunology|August 30, 2001

Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on T(h)1 cells that is augmented by IL-4G T Tran, N Carter, X Y He, et al.

Pageof 2